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Background: Some species of fungi can cause serious human diseases, particularly to immuno-compromised individuals.
Opportunistic fungal infections are a leading cause of mortality, and present an emerging challenge that requires
development of new and effective therapeutics. Aminoacyl-tRNA synthetases (aaRSs) are indispensable components of
cellular protein translation machinery and can be targeted for discovery of novel anti-fungal agents.
Results: Validation of aaRSs as potential drug targets in pathogenic microbes prompted us to investigate the genomic
distribution of aaRSs within three fungi that infect humans – A. niger, C. albicans and C. neoformans. Hidden Markov
Models were built for aaRSs and related proteins to search for homologues in these fungal genomes. Here, we provide a
detailed and comprehensive annotation for 3 fungal genome aaRSs and their associated proteins. We delineate
predicted localizations, subdomain architectures and prevalence of unusual motifs within these aaRSs. Several fungal
aaRSs have unique domain appendages of unknown function e.g. A. niger AsxRS and C. neoformans TyrRS have
additional domains that are absent from human homologs.
Conclusions: Detailed comparisons of fungal aaRSs with human homologs suggest key differences that could be
exploited for specific drug targeting. Our cataloging and structural analyses provide a comprehensive foundation for
experimentally dissecting fungal aaRSs that may enable development of new anti-fungal agents.
Keywords: Aminoacyl-tRNA synthetases, Domain organization, Drug targets, Fungal pathogensBackground
Fungal infections are emerging as a leading cause of
human mortality in hospital settings [1-5]. Recent trends
suggest that select species of fungi have the ability to take
advantage of debilitated immune system to cause mortality
[1-5]. Data suggest that diseases caused by opportunistic
fungi result in scores of human deaths worldwide, and
hence containment of human fungal infections is a press-
ing challenge [1-5]. The pathogenesis of such opportunis-
tic fungi is a complex phenomenon since these organisms
more often than not lack dedicated ‘virulence’ factors
[1-5]. Therefore, understanding cellular and molecular* Correspondence: amit.icgeb@gmail.com
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article, unless otherwise stated.attributes of these fungal pathogens is indispensible to-
wards developing effective therapeutics.
Aspergillus, Candida, and Crytococcus are the three
most common genus of fungi associated with infectious
diseases in humans [1-5]. Candidiasis or thrush is the
most prevalent fungal infection in humans, commonly
caused by C. albicans. Candida is generally present on
the skin and mucous membrane and does not cause in-
fection, however invasive candidiasis occurs when Candida
enters the bloodstream and spreads throughout the body
[6]. Immuno-compromised (as in case of cancer and AIDS
patients) individuals are particularly prone to C. albicans
infections [7]. Aspergillus species causes second most com-
mon fungal infections in humans [8]. A. fumigates is the
most virulent species in this genus, and cases of pulmonary
aspergillosis have been reported resulting from A. nigerntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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caused primarily by the two species Cryptococcus neofor-
mans and Cryptococcus gattii [10]. C. neoformans is present
in soil and spreads through microscopic airborne fungal
spores [11]. C. neoformans infection increases the probabil-
ity of re-hospitalization of AIDS patients who otherwise
show positive response to anti-retroviral therapy [7,12]. A.
niger and C. albicans belong to Ascomycota phylum while
C. neoformans belongs to Basidomycota phylum within the
fungal kingdom. Genome sizes for A. niger, C. albicans,
and C. neoformans are ~33 Mb (19 chromosomes), ~14
Mb (8 chromosomes), and ~19 Mb (14 chromosomes).
Predicted number of ORFs (open reading frames) in A.
niger, C. albicans, and C. neoformans are ~14000, ~6200,
and ~6500. In addition to genome sequencing, tran-
scriptomics analyses for these three fungi are also avail-
able [13-15].
Aminoacyl-tRNA synthetases (aaRSs) drive protein trans-
lational machinery by catalyzing the addition of amino
acids to cognate tRNA [16,17]. Structural studies have
confirmed their modular architecture, with separate do-
mains for aminoacylation and tRNA binding [16-18].
Based on their structural fold and mode of tRNA binding
these enzymes have been classified into class I and II aaRSs
[16-18]. In addition to performing translational activities,
these proteins also localize within mitochondria and api-
coplasts to participate in synthesis of proteins encoded by
genomes within organelles [16-21]. Aside from their trans-
lational functions, aaRSs are implicated in various non-
canonical functions such as gene transcription, mRNA
translation, inflammation, and immune response [16-21].
Therefore, aaRSs constitute a very important subset of
proteins in any genome, and inhibition of their enzymatic
activity can be deleterious for the host. Ever since the
potential of malaria parasitic aaRSs for exploration as new
drug targets has been highlighted [19,22], intense efforts
from many groups have yielded an array of druggable mal-
aria parasite aaRSs [23-35]. More recently, protein transla-
tion components from other eukaryotic pathogens like
Leishmania [36] and Toxoplasma [21] have also been
explored. Hence, experimental dissection of critical trans-
lation components like aaRSs is on high priority as one
avenue of novel target discovery in pathogen biology.
Dearth of structural characterization of larger number of
fungal aaRSs severely restricts scope for targeted deve-
lopment of new anti-aaRS drugs, despite the acceptance
of aaRSs as druggable targets. In context of this work, C.
albicans SerRS is the only full-length aaRS from these
three fungal genomes for which crystal structure has been
solved [37]. Here, we have studied aaRSs from A. niger, C.
albicans and C. neoformans using profile-based Hidden
Markov Models (HMM). In addition, homologs for aaRS-
related proteins such as the editing domains (AlaX) and D-
tyrosyl-deacylase (DTD), Gln and Asn amidotransferases,and aaRS-associated P43 protein have also been identified.
Protein sequences of thus identified aaRSs have been
comprehensively annotated in context of their domain
organization. We discovered novel domain appendages in
several fungal aaRSs that are absent from human homologs.
Our results highlight key structural attributes of fungal
aaRSs that could be exploited for drug targeting to combat
mycoses in humans.
Methods
Retrieval of fungal genome sequences and aaRS dataset
Computationally translated open reading frames (ORFs)
for A. niger and C. albicans were downloaded from their
corresponding genome databases available at http://www.
aspergillusgenome.org/ and http://www.candidagenome.
org/ respectively. Similarly, ORF sequences for C. neofor-
mans were retrieved from FungiDB [38]. To annotate
aaRSs and aaRS-associated proteins, a dataset of anno-
tated aaRSs and associated proteins was prepared from
the UniProt database [39]. Our dataset included protein
sequences of human aaRSs, human aaRS trans-editing
domain (DTD, AlaX), Gln and Asn amidotransferases,
aaRS associated protein P43 and Ybak protein from E. coli.
The UniProt accession numbers for sequences in the data-
set are given in supplementary Additional file 1: Table S1.
Generation of Hidden Markov Models (HMMs), protein
annotation and modeling
All protein sequences from our dataset were individually
used to perform BLAST searches against non-redundant
databases available at NCBI. Top 1000 homologs from
each BLAST search were saved for further analyses as
we reasoned that these may effectively capture the
evolutionary diversity at different positions within aaRSs,
thus facilitating generation of robust HMMs. For each
aaRS, HMMs were generated using the homologs identi-
fied from BLAST search. Sequence Alignment and Mod-
eling Software System (SAM) [40] was used to generate
MSA, and HMMER package was used for building pro-
file HMM for each MSA. Significantly similar matches
for each HMM profile were identified within the gen-
omic sequences from the three fungi. Pfam [41] domains
were assigned to predicted aaRS sequences from fungal
genomes. Sub-cellular localization for sequences show-
ing significant HMM search score was annotated using
Wolf PSORTb webserver using default parameters
optimized for fungal proteins [42]. For a query protein
sequence, this server gives a relative score to each sub-
cellular location and the highest scoring compartment
has been used here to annotate aaRSs. MitoProt [43]
and TagetP [44] servers were used to identify signal
sequences within the predicted mitochondrial aaRSs.
Sequence alignment of aaRSs was performed using T-
coffee program with default parameters [45]. Structural
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using Expresso options available at http://tcoffee.crg.cat/.
Homology modeling for protein sequences was per-
formed using Phyre2 server [46] and PyMol [47] was
used for structure visualization and analyses.
Results and discussion
We have employed a profile HMM-based search to com-
putationally identify aaRSs in the three fungal genomes.
Our results show that there are a total of 29 aaRSs in A.
niger, 28 in C. albicans and 26 in C. neoformans (Tables 1,
2 and 3). This exercise enabled us to annotate aaRSs
specific for all 20 amino acids in these fungi (Tables 1, 2
and 3). All predicted aaRSs had highly significant e-values
based on profile HMM searches. Functional annotation of
these aaRSs was cross-validated using BLAST searches
against conserved domain database (CDD) at NCBI.
Amongst the three fungi, maximum variation in the full
length of aaRSs was observed in A. niger genome with the
largest and smallest proteins being IleRS (212883-mRNA)
with 1524 residues and TrpRS (209919-mRNA) with
391 residues respectively (Table 1). Interestingly, for some
aaRSs there exist multiple enzymes for charging tRNAs
that are specific to a particular amino acid (Figure 1). Our
results show that there are 8 A. niger aaRSs that are present
in two versions (AspRS, GluRS, GlyRS, IleRS, LeuRS,
PheRS, TrpRS and AsxRS), 7 C. albicans aaRSs that are
present in two versions (GluRS, IleRS, LeuRS, PheRS,
TrpRS, TyrRS and AsxRS), and 5 C. neoformans aaRSs that
are present in two versions (AsnRS, GluRS, IleRS, PheRS
and TyrRS, Figure 1A). These two versions of aaRSs would
presumably facilitate localization in different sub-cellular
compartments e.g. in cytoplasm and mitochondria.
Comparisons amongst the three fungi show GluRS, IleRS,
LeuRS and PheRS to be the common set of two-copy
enzymes. To analyze compartmentalization of aaRSs, sub-
cellular localization was calculated for all predicted aaRSs.
Expectedly, this showed that whenever two same amino
acid aaRSs were present, one was predicted to be cyto-
plasmic while the other mitochondrial (Tables 1, 2 and 3).
We then were able to compile predicted sub-cellular
distribution for all aaRSs (Figure 1B), along with putative
signal sequences for mitochondrial aaRSs (Additional file 1:
Figure S1). Out of total 29 A. niger aaRSs – 16, 11, and 2
aaRS(s) were predicted to (co-) localize in cytoplasm,
mitochondria and nucleus (Figure 1B and Table 1). In C.
albicans 13, 9 and 6 aaRSs were predicted to be cyto-
plasmic, mitochondrial and nuclear (Figure 1B and Table 2).
Finally, C. neoformans aaRSs were predicted to be equally
partitioned between cytoplasm and mitochondria with 13
aaRSs in each (Figure 1B and Table 3). This analysis
presents a conundrum where none of the translational
compartments in the three fungi seem independent for
generating all 20 charged tRNAs. It is likely that some ofthe identified aaRSs have dual sub-cellular localizations
within the cell. In addition, transport of charged tRNAs
between cellular compartments could compensate for
absence of any particular aaRS in a given chamber like
cytoplasm or mitochondria, as in the case of other
organisms [48].
We also sought to catalog trans-editing domains within
these fungal genomes. D-Tyrosyl-tRNATyr deacylase
(DTD) catalyzes hydrolysis of bond between D-amino-
acid and tRNA. These enzymes play an important role in
evading toxicity resulting from accumulations of D-amino
acids within the cell [49]. Trans-editing domains such as
AlaX maintain fidelity of tRNA charging by hydrolyzing
incorrectly charged amino acid attached to tRNAAla [50].
Hence, in addition to profile HMM search for 20 canon-
ical aaRSs; screening for aaRS-associated proteins was also
performed (see Methods section for details). Our results
suggest that trans-editing domains such as DTD and AlaX
are found in all the three fungi (Tables 1, 2 and 3). Simi-
larly, the possibility of alternate route for Gln-tRNAGln
and Asn-tRNAAsn synthesis was examined [33,51]. In this
alternate mechanism, a non-discriminating aaRS catalyze
the synthesis of Glu-tRNAGln or Asp-tRNAAsn followed by
catalysis by a corresponding amidotransferase to generate
Gln-tRNAGln or Asn-tRNAAsn respectively. Curiously, two
separate proteins corresponding to amidotransferase (Asn
synthase) were observed in all the three fungal genomes
(Tables 1, 2 and 3). The existence of Asn synthase cor-
roborates with the presence of above identified non-
discriminating domains (AsxRS) within the host fungi
(Tables 1, 2 and 3). Similar to Asn synthase, Gln synthase
is a transamidase that catalyzes the synthesis of Gln-
tRNAGln from Glu-tRNAGln. In mammals, heterotrimeric
Gln synthase (GatABC) is frequently observed within
mitochondria for synthesis of Gln-tRNAGln [52]. In
addition to aminoacylation activity, subunit proteins of
Gln synthase have been shown to be important for proper
functioning of mitochondrial activities unrelated to pro-
tein translation [52]. We additionally identified homologs
for subunit A and B of Gln synthase in the three fungi
(Tables 1, 2 and 3), however, homologs for GatF subunit
could be ascertained only in case of A. niger and C.
albicans.
In some eukaryotes, a few aaRSs associate with each
other and with auxillary proteins (called P18, P38, and P43)
to form multi-synthetase complex (MSC) [53,54]. It has
been proposed that MSC improves translational efficiency
by channeling tRNAs to aaRSs and ribosomes [55]. In
addition, MSC may serve as a reservoir of pro-cytokines
and other regulatory molecules that can be released per
physiological requirements [56]. A central component of
MSC is P43, a polypeptide of ~43 kDa that harbors tRNA
binding domain. P43 is associated with multitude of cellular
functions such as protein synthesis, axonal development,
Table 1 ORFs in A. niger having aaRS or associated domains








Class I ArgRS 197261-mRNA Cyto 646 NA 36
CysRS 211236-mRNA Cyto 804 0 39
GlnRS 45754-mRNA Cyto 625 4.4e-247 44
GluRS 56891-mRNA Nucl 712 0 45
GluRS 121468-mRNA Mito 427 3.5e-155 37
IleRS 52642-mRNA Cyto 1077 0 53
IleRS 212883-mRNA Mito 1524 0 36
LeuRS 183116-mRNA Mito 989 0 38
LeuRS 52554-mRNA Cyto 1126 0 45
MetRS 208481-mRNA Cyto 659 0 48
TrpRS 54362-mRNA Cyto 433 6e-156 55
TrpRS 209919-mRNA Mito 391 6e-156 40
TyrRS 54566-mRNA Mito 611 5.1e-123 41
ValRS 194077-mRNA Cyto 1315 0 46
Class II AlaRS 51231-mRNA Mito 1019 7.4e-37 48
AsnRS 210632-mRNA Mito 543 1.5e-146 37
AspRS 57039-mRNA Mito 676 9.5e-179 38
AspRS 56196-mRNA Cyto 559 3.5e-281 48
AsxRS 207470-mRNA Cyto_nucl 574 4.7e-270 50
AsxRS 55404-mRNA Nucl 952 0 45
GlyRS 57294-mRNA Mito 738 0 51
GlyRS 50342-mRNA Cyto 667 0 47
HisRS 51854-mRNA Mito 619 1.4e-287 53
LysRS 47873-mRNA Cyto 604 0 57
PheRS 55517-mRNA Mito 514 3.8e-230 38
PheRS α 56159-mRNA Cyto 518 2.8e-254 47
PheRS β 211951-mRNA Cyto_nucl 600 0 47
ProRS 210319-mRNA Cyto 604 0 53
SerRS 57312-mRNA Cyto 474 5.2e-262 48
ThrRS 51819-mRNA Cyto 718 0 50
aaRS related proteins AlaX 189390-mRNA Cyto 271 1.4e-33 24
DTD 56197-mRNA Cyto_mito 191 NA 47
P43 homolog 210303-mRNA Cyto 445 3.1e-159 42
Asn synthase 57091-mRNA Mito 573 8.8e-57 34
Asn synthase 186429-mRNA Cyto 694 1.5e-39 27
GatA 170115-mRNA Extr 504 1.7e-159 39
GatB 172989-mRNA Mito 601 2.2e-138 33
GatF 173432-mRNA Mito 886 8.1e-12 NA
NA in e-value indicates fungal sequences that could be identified by HMM search and were retrieved from NCBI using keyword search.
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profile HMM-based screening revealed existence of P43
variants in all the three fungal genomes (Tables 1, 2 and 3).
Presence of MSC and its constituents now remain to be
addressed experimentally.Domain architecture for aaRSs in A. niger
Profile HMM searches identified a total of 29 aaRS in A.
niger – 14 belonging to class I and 15 to class II. Among
class I aaRSs – IleRS, LeuRS, GlnRS, ArgRS, and MetRS
had N-terminal catalytic domain followed by anticodon
Table 2 ORFs in C. albicans having aaRS or associated domains
aaRS domain ORF Predicted sub-cellular
localization




Class I ArgRS orf19.3341 Cyto 622 1.2e-104 38
CysRS orf19.4931 Mito 781 0 42
GlnRS orf19.7064 Cyto 799 0 38
GluRS orf19.2415 Mito 509 1.9e-199 35
GluRS orf19.7057 Cyto 725 NA 42
IleRS orf19.2138 Nucl 1088 0 53
IleRS orf19.2382 Mito 973 0 36
LeuRS orf19.2560 Cyto 1097 0 46
LeuRS orf19.5705 Cyto 861 0 37
MetRS orf19.3955 Cyto 748 0 51
TrpRS orf19.5226 Cyto 424 3e-235 56
TrpRS orf19.4299 Nucl 399 4.8e-156 42
TyrRS orf19.2694 Cyto 409 3.8e-170 53
TyrRS orf19.109 Mito 501 7.3e-152 34
ValRS orf19.1295 Mito 1119 0 48
Class II AlaRS orf19.5746 Cyto 969 0 50
AsnRS orf19.6698 Mito 489 6.2e-146 35
AspRS orf19.4478 Mito 698 5.5e-173 35
AsxRS orf19.2407 Cyto 578 0 58
AsxRS orf19.6702 Cyto 552 1.3e-261 52
GlyRS orf19.437 Nucl 652 0 50
HisRS orf19.4051 Mito 501 2.3e-271 52
LysRS orf19.6749 Nucl 594 0 56
PheRS orf19.2039 Mito 446 8.8e-218 39
PheRS α orf19.2960 Cyto 496 3.2e-244 47
PheRS β orf19.2573 Cyto_nucl 592 1.1e-284 45
ProRS orf19.6701 Cyto 691 0 57
SerRS orf19.269 Nucl 458 3.8e-245 46
ThrRS orf19.5685 Nucl 706 0 59
aaRS related proteins DTD2 orf19.297 Cyto 163 NA 48
AlaX orf19.5239 Cyto_nucl 471 2.1e-127 31
P43 homolog orf19.2422 Cyto 369 1.9e-130 53
Asn synthase orf19.3626 Nucl 704 1e-178 25
Asn synthase orf19.198 Cyto 573 1.1e-58 35
GatA orf19.3956 Mito 450 1.7e-135 34
GatB orf19.2494 Nucl 488 9.7e-141 32
GatF orf19.4092 Nucl 165 NA NA
NA in e-value indicates fungal sequences that could be identified by HMM search and were retrieved from NCBI using keyword search.
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Two different proteins corresponding to IleRS were pre-
dicted to localize in cytoplasm (52642-mRNA) and extra-
cellular space (212883-mRNA) respectively. However, the
synthetase domain of IleRS (212883-mRNA) shares ~36%
sequence identity with human mitochondrial IleRS andtherefore its sub-cellular localization is likely to be mito-
chondrial rather than extracellular. Interestingly, one IleRS
(212883-mRNA) contains an addition uncharacterized pro-
tein family (UPF0183) domain at its N-terminal (Figure 2).
BLAST searches for this IleRS (212883-mRNA) against
human genome failed to identify a homolog for the UPF
Table 3 ORFs in C. neoformans having aaRS or associated domains
aaRS domain ORF Predicted sub-cellular
localization




Class I ArgRS CNBG3480 Cyto 622 NA 37
CysRS CNBB4810 Cyto 785 0 42
GlnRS CNBA0720 Cyto 858 5.2e-300 40
GluRS CNBK2470 Mito 588 2.3e-197 35
GluRS CNBF4640 Cyto 728 3.1e-295 43
IleRS CNBA2140 Cyto_nucl 1094 0 51
IleRS CNBN1610 Mito 1032 0 36
LeuRS CNBM1150 Cyto 1114 0 46
MetRS CNBD2070 Cyto 724 0 46
TrpRS CNBJ3070 Mito 641 5.5e-221 55
TyrRS CNBA1270 Cyto 819 3.3e-218 47
TyrRS CNBJ0260 Mito 478 1.2e-169 47
ValRS CNBB3840 Mito 1109 0 47
Class II AlaRS CNBF2180 Mito 1012 0 49
AsnRS CNBD2410 Mito 513 1.7e-157 38
AsnRS CNBE1330 Cyto 600 1.8e-251 48
AspRS CNBK1200 Mito 693 8.5e-193 36
AsxRS CNBG4380 Cyto 884 0 42
GlyRS CNBF3810 Cyto 673 0 46
HisRS CNBC0810 Mito 586 4.2e-270 47
LysRS CNBH3030 Mito 630 0 52
PheRS CNBC0600 Mito 476 4.5e-214 40
PheRS α CNBJ1210 Cyto 510 1.1e-250 51
PheRS β CNBC3360 Nucl 632 4.1e-283 44
ProRS CNBB0150 Mito 740 0 55
SerRS CNBD0870 Cyto 461 2.6e-225 40
ThrRS CNBB5220 Mito 772 0 56
aaRS related proteins AlaX CNBA4150 Cyto 523 1.1e-108 29
DTD CNBB3530 Cyto 234 1e-41 47
P43 homolog CNBF3180 Cyto 383 1.8e-124 47
Asn synthase CNBK3010 Mito 572 1.7e-196 34
Asn synthase CNBL0870 Mito 592 1.6e-65 34
GatA CNBD1400 Mito 493 1.7e-119 33
GatB CNBG4210 Mito 521 1.7e-176 37
NA in e-value indicates fungal sequences that could be identified by HMM search and were retrieved from NCBI using keyword search.
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for LeuRS were identified, putatively localized to cyto-
plasm (52554-mRNA) and mitochondria (183116-mRNA).
Mitochondrial (121468-mRNA) and potentially nuclear
(565891-mRNA) copies of GluRS were also identified. In
latter, an additional glutathione-S-transferase C-terminal
domain (GST_C, an α-helix containing structural domain)
is evident at the N-terminus. Human bifunctional GluRS/
ProRS also contains GST_C domain at the N-terminusand these proteins shares 45% identity with A. niger
GluRS. The GST_C domain fusion is also present in
human MetRS and ValRS. Curiously, the GlnRS (45754-
mRNA) lacks N-terminal RNA binding region that is
present in human and other fungal homologs (Figure 2).
The TrpRSs are two-copy enzymes in A. niger, one each
for cytoplasm (54362-mRNA) and mitochondria (209919-
mRNA). In case of CysRS, GluRS, MetRS, TrpRS and
TyrRS the Pfam server could only annotate their catalytic
BA
Figure 1 Hidden Markov Model (HMM) based prediction of aaRSs in fungal genomes. (A) Number of predicted aminoacyl-tRNA synthetases
(aaRSs) in the three fungal genomes. (B) Predicted distribution of aaRSs in the sub-cellular compartments of the three fungal pathogens. The
aaRSs are denoted by the single letter code for their corresponding amino acid and Asx refers to non-discriminating aspartyl-tRNA synthetase.
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catalytic domain positioning it appears likely that their
anti-codon binding domains lie towards the C-termini
(Figure 2).Surprisingly, A. niger ValRS (194077-mRNA) displays an
additional Brix domain at its C-terminus (Figure 2).
Protein families containing Brix domain participate in
ribosomal biogenesis and rRNA binding [58]. These
Figure 2 Domain annotations for predicted aminoacyl-tRNA synthetases (aaRSs) in A. niger. Catalytic domains are labeled with three letter
code for corresponding aaRS and number at the end of sequence denotes the length of the protein. ABD - Anti-codon binding, FDX - Ferridoxin-fold
ABD, UPF - Unknown protein family, GST - Glutathione-S-transferase, NT - N-terminal, CT - C-terminal, DUF2156 - Domain of unknown function,
SAD - Second associated domain.
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ValRS (194077-mRNA) to participate in rRNA production.
The Brix domain in ValRS (194077-mRNA) appears to be
unique to A. niger and is not observed in Human ValRSs
(Figure 3B). In order to manually annotate the gene for A.
niger VRS (having Brix domain fusion), BLAST searches
for 194077-mRNA were performed against the A. niger
transcriptome database located at the Broad Institute,
USA. A highly significant hit was obtained spanning the
fungal full-length protein sequence (Additional file 1:
Figure S2A). These results indicate that chromosome 16
within A. niger genome codes for VRS-Brix domain fusion
protein. Structural modeling for the Brix domain from
194077-mRNA confirms conservation in the catalytic
fold with respect to its homologs (Additional file 1:
Figure S2B).The class II set of aaRSs in A. niger showed heterogeneity
in the relative organization of catalytic and anti-codon bind-
ing (ABD) domains. AlaRS, PheRS, GlyRS, HisRS, ProRS
and ThrRS had catalytic domains at the N-termini of anti-
codon binding domain (Figure 2). While in case of LysRS,
SerRS and AsxRS the catalytic domain is present at the C-
terminal of the anti-codon binding domain (Figure 2).
AspRSs (56196-mRNA and 57039-mRNA) were the only
class II proteins in A. niger for which anti-codon binding
domain could not be annotated. However, based on Pfam
assignment of catalytic domain in these proteins it appears
likely that the ABD lies at the N-terminal region (Figure 2).
In case of PheRS, two proteins were found with different
predicted sub-cellular localization. Cytoplasmic PheRS was
predicted to be a heterodimer comprising of α (56159-
mRNA) and β (211951-mRNA) subunits. On the other
CB
A
Figure 3 Comparison of domain architectures of A. niger and H. sapiens aaRSs. Homologous proteins from C. albicans and C. neoformans are
also shown. (A) An uncharacterized protein family (UPF) domain at the N-terminal of A. niger IleRS (212883-mRNA) is absent in the homolog from
H. sapiens. A. niger and H. sapiens IleRSs share ~36% sequence identity. (B) Comparison of domain architectures of ValRS from A. niger (194077-mRNA)
and H. sapiens. Brix domain at the C-terminal is unique to A. niger ValRS, and these two ValRSs are ~46% identical. (C) A. niger AsxRS has a unique
domain of unknown function (DUF) C-terminal to the catalytic domain. A. niger AsxRS and H. sapiens AspRS are ~45% identical.
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doxin fold containing anti-codon binding domain (Figure 2).
These observations suggest that the quaternary (tetrameric)
structure of mitochondrial PherRS (55517-mRNA) com-
prises only of one protomer while cytoplasmic PheRS has
αβ heterodimer as the basic subunit of the tetramer.
Interestingly, we identified two non-discriminating
aspartyl-tRNA synthetases (AsxRS) that were predicted
to localize in cytoplasm (207470-mRNA) and nucleus
(55404-mRNA) respectively. These enzymes catalyze the
charging of both tRNAAsp and tRNAAsn with aspartate
[51]. Asp-tRNAAsn thus generated is further acted upon
by amidotransferase leading to synthesis of Asn-tRNAAsn
[59]. Curiously, one AsxRS (55404-mRNA), predicted to
have nuclear location, has an additional domain of
unknown function (DUF) at the C-terminal (Figure 2)
which is missing from the human homolog (Figure 3C).
Profile HMM searches for the amidotransferases identified
two Asn synthase – 57091-mRNA (mitochondrial) and
186429-mRNA (cytoplasmic) (Figure 2). These amido-
tranferases together with non-discriminating aspartyl-
tRNA synthetase (AsxRS) likely participate in the indirect
synthesis of Asn-tRNAAsn. Our results show that there is
only one AsnRS which is localized in mitochondria.Therefore it appears that the mitochondrial repertoire of
Asn-tRNAAsn is maintained by AsnRS as well as by the
combined activity of AsxRS and Asn synthase. The cyto-
plasmic pool of Asn-tRNAAsn is likely maintained only by
the collective activity of AsxRS and Asn synthase enzymes.
Homologs for Gln synthase subunits A (170115-mRNA), B
(172989-mRNA) and F (173432-mRNA) were also identi-
fied (Table 1). These three subunits together constitute an
active GatFAB enzyme within the mitochondria and
facilitate the synthesis of Gln-tRNAGln within the organelle.
Curiously, GatF (173432-mRNA) has an additional domain
(DUF726) at its C-terminal (Figure 2). It is possible that
the mitochondrial GluRS, like its human homolog, is
essentially a non-discriminating enzyme that synthesizes
Glu-tRNAGln which acts as a substrate for heterodimeric
Gln synthase to yield Gln-tRNAGln.
Significant matches for standalone trans-editing and dea-
cylase domains were also observed for two proteins –
189390-mRNA and 56197-mRNA that contains AlaX and
DTD domains respectively. We also identified a P43 homo-
log (210303-mRNA) in A. niger. Interestingly, A. niger P43
has GST C-terminal domain at the N-terminal of the
tRNA binding region, which is different from the human
counterpart. Indeed, GST_C domain is absent in
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from Toxoplasma gondii [17] (Figure 4A). Multiple se-
quence alignment for P43 homologs shows high conserva-
tion in the tRNA binding domains between human, the
three fungi, and T. gondii P43s (Figure 4B). However, A.
niger P43 sequence has two insertions (one of 4 residues
and another of 9 residues) within the structurally conserved
tRNA binding domain. Further, the N-termini of these pro-
teins show poor homology amongst each other. Finally,
GluRS (56891-mRNA), HisRS (51854-mRNA), and LeuRS
(52554-mRNA) were observed to have ‘ELR’ motifs in their
N-terminal regions (Additional file 1: Table S2). In human
and other TyrRSs this motif can impart cytokine-related ac-
tivities [21,60-62] which are untested in the three fungi so
far. Mapping of ELR motifs onto the modeled structures
showed that the ELR motif appeared in surface exposed
loop regions in these three aaRSs (data not shown).
Domain architecture for aaRSs in C. albicans
The total number of aaRSs identified in C. albicans was 28
with 15 and 13 members in class I and class II respectively.
The general organization of domains amongst class I aaRSs
was prototypical: catalytic domain followed by anticodon
binding domain (Figure 5). For ~50% of class I aaRSs, two
different proteins were identified specific for a particular
amino acid – presumably one aaRS each for cytoplasm and
mitochondria (Figure 5). Class I aaRSs for which only one
copy was identified includes CysRS (orf19.4931), MetRS
(orf19.3955), GlnRS (orf19.7064), ArgRS (orf19.3341), and
ValRS (orf19.1295). The cytoplasmic copy of GluRS
(orf19.7057) had an additional glutathione-S-transferase
(GST_C) domain appended at the N-terminus (Figure 5),
like the human bifunctional glutamate/proline–tRNA syn-
thetase. In case of MetRS (orf19.3955), an additional N-
terminal domain was identified based on Pfam annotation.
This domain is again unique to C. albicans MetRS and is
absent from the other two fungal MetRSs analyzed here as
well as from the human MetRS (Figure 5). Two proteins
each for IleRS (orf19.2138 and orf19.2382) and LeuRS
(orf19.2560 and 5705) were predicted to have anti-codon
binding domain at the C-terminal of catalytic domain
(Figure 5). Two differentially localized proteins each for
TrpRS (orf19.4299 and orf19.5226) and TyrRS (orf19.109
and orf19.2694) were also identified (Table 2 and Figure 5).
Class II aaRSs were generally present as a single protein
except for PheRS and AsxRS. The two PheRSs had differ-
ent predicted sub-cellular localization with one likely in
cytoplasm and other in mitochondria. Like the A. niger
mitochondrial PheRS, C. albicans homolog (orf19.2039)
also has anti-codon binding domain at the C-terminal of
catalytic domain. Further, cytoplasmic PheRS prototypic-
ally encompass α (orf19.2960) and β (orf19.2573) subunits
(Figure 5). The AlaRS (orf19.5746) has second associated
domain (SAD) and DHHA1 domains C-terminal to itscatalytic domain (Figure 5). These two domains are char-
acteristic of AlaRSs and contribute to the catalytic activity
of the enzyme [63]. ProRS (orf19.6701), in addition to
catalytic and anti-codon binding domains, had two add-
itional domains one at its termini: N-terminal (editing do-
main) and a C-terminal domain. ThrRS (orf19.5685) had
TGS (ThrRS, GTPase, and SpoT) and SAD (second
additional domain) domains present N-terminal to cata-
lytic domain (Figure 5). Two separate non-discriminating
aspartyl-tRNA synthetase (AsxRS) were also identified –
orf19.6702 and orf19.2407 (Figure 5).
Amongst aaRS-associated proteins, two Asn synthases
were identified in C. albicans – orf19.3626 (predicted nu-
clear) and orf19.198 (predicted cytoplasm). These two en-
zymes could act in tandem with two AsxRSs to generate
Asn-tRNAAsn in an indirect manner. In addition, subunit
components of Gln synthase were also identified – GatA
(orf19.3956), GatB (orf19.2494) and GatF (orf19.4092)
(Table 2 and Figure 5). C. albicans mitochondrial GluRS
(orf19.2415) shares ~35% identity with human mitochon-
drial GluRS (which is non-discriminating), raising the pos-
sibility of indirect synthesis of Gln-tRNAGln by the action
of Gln synthase on Glu-tRNAGln. Standalone trans-editing
domains like AlaX (orf19.5239) and DTD (orf19.297) were
also identified (Figure 5). Our results confirm the presence
of P43 homolog (orf19.2422) within the C. albicans gen-
ome (Figure 5). Three aaRSs – GluRS, HisRS, and LysRS
in C. albicans have ‘ELR’ motif at the N-terminal region
(Additional file 1: Table S2). The ELR motifs in these three
aaRSs were surface exposed in modeled three-dimensional
structures (data not shown).
Domain architecture for aaRSs in C. neoformans
Profile HMM-based searches identified 26 aaRSs with 13
each belonging to class I or II (Figure 6). Amongst class II
aaRSs, two aaRSs were observed only for PheRS and GlnRS.
The gene structures for other class II aaRSs were mostly
similar to those described for A. niger and C. albicans. Two
encoded proteins were observed for IleRS (CNBN1610 and
CNBA2140) and TyrRS (CNBA1270 and CNBJ0260)
(Table 3). Intriguingly, in one of the TyrRSs (CNBA1270),
a SAICAR domain (a protein module that synthesizes 4-
(N-succinylcarboxamide)-5-aminoimidazole ribonucleotide)
was identified towards the C-terminal in fusion with the
prototypical TyrRS. Predicted sub-cellular localization sug-
gests this unusual fusion TyrRS (CNBA1270) to be cyto-
plasmic. Other SAICAR domain containing proteins (such
as phospho-ribosyl-amino-imidazole-succino-carboxamide
synthase) are involved in de novo purine biosynthetic path-
way and catalyze the following reaction [64]:
ATPþ L−aspartateþ 4−carboxy−5
−aminoimidazole ribonucleotide CAIRð Þ
⇌ADPþ Piþ SAICAR
BA
Figure 4 (See legend on next page.)
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Figure 4 Comparison of P43 homologs from different genomes. (A) Pfam-based domain organization for P43 homologs from Homo sapiens
(Hs), A. niger (An), C. albicans (Ca), C. neoformans (Cn), and Toxoplasma gondii (Tg). (B) Sequence alignment for P43s with color codes showing
sequence conservation – low (blue) to high (red). Overall, there is high conservation in the tRNA-binding domain at the C-terminal and poor
homology at the N-terminals.
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from their microbial homologs both in terms of subunit
structure (vertebrate SAICAR synthetase are multimeric
proteins) and functions (vertebrates have bifunctional
enzymes having AIR carboxylase and SAICAR synthetase
activity [65]). A recent study has suggested microbial SAI-
CAR synthetases as potential drug target [66]. Significantly,
we could not identify a homolog for TyrRS-SAICAR fusion
protein (CNBA1270) in humans and hence these unusual
fused domains seems unique to C. neoformans (Figure 7A).
Intriguingly, BLAST searches against non-redundant data-
bases revealed that homologs for TyrRS-SAICAR fusion
protein exist only in some other fungi such as CryptococcusFigure 5 Domain annotations for predicted aminoacyl-tRNA synthetase
code for corresponding aaRS and number at the end of the sequence denote
and SpoT) domain, RBR – non-specific RNA binding region, DHHA1 - DHH assgatti, Trichosporon asahii and Tremella mesenterica. In
order to validate this domain fusion in the case of C. neofor-
mans, BLAST searches for CNBA1270 were done against
transcriptome database available at BROAD institute, USA.
A highly significant transcript was obtained correspond-
ing to the computationally predicted protein sequence
(Additional file 1: Figure S3). These results reinforce pres-
ence of a chromosomal region in C. neoformans genome
that encodes for YRS-SAICAR fusion protein. Modeling of
the tertiary structure for SAICAR domain in CNBA1270
confirmed conservation of key residues within the ATP
binding pocket (Figure 7B). These observations further
substantiate the hypothesis that this fusion domain proteins (aaRSs) in C. albicans. Catalytic domains are labeled with three letter
s the length of the protein. ED - Editing domain, TGS – (ThrRS, GTPase,
ociated domain, and other domains are same as in Figure 2.
Figure 6 Domain annotations for predicted aminoacyl-tRNA synthetases (aaRSs) in C. neoformans. The catalytic domains are labeled with
three letter code for corresponding aaRS and number at the end of the sequence denotes the length of the protein. DALR_1 - (Asp, Ala, Leu, and
Arg) domain, SAICAR - Phosphoribosylaminoimidazolesuccinocarboxamide domain. Other domains are same as in Figure 2.
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against C. neoformans.
Among aaRS related proteins, four polypeptides were
predicted to have amidotransferases activity – two Asn
synthases (CNBK3010 and CNBL0870) and other two
Gln synthases (subunit A (CNBD1400) and subunit B
(CNBG4210)). We were not able to identify any homolog
for GatF subunit. Interestingly, all these four amidotran-
ferases were predicted to localize within the mitochondria
(Table 3). In addition, a standalone trans-editing AlaX
(CNBA4150) and DTD (CNBB3530) were also identified
(Figure 6). Interestingly, the mitochondrial TyrRS-SAICAR
fusion protein (CNBJ0260) had an ‘ELR’ motif at its N-
terminal (Additional file 1: Table S2). This motif in human
TyrRS is responsible for cytokine activity. Structural mod-
eling for C. neoformans TyrRS part of the fusion protein
suggests that the ‘ELR’ motif is likely to be solvent access-
ible (Figure 8A). Further, the ‘ELR’ motifs in human and
C. neoformans TyrRSs are part of α helices that super-
impose well (Figure 8B). Presence of ELR motif at the
N-terminal and an additional unique SAICAR domain
towards C-terminal makes C. neoformans mitochondrialTyrRS (CNBJ0260) an interesting target for further inves-
tigation. In addition, we noted that ProRS (CNBB0150)
also has an ‘ELR’ motif towards its N-terminal (Additional
file 1: Table S2), which when modeled indicated surface
exposure for this motif.
Conclusions
Treatment and prevention of opportunistic fungal infections
in humans presents an emerging challenge. Aspergillus,
Candida and Cryptococcus are three highly pathogenic
fungi, particularly in immuno-compromised patients. Dis-
secting and understanding critical fungal protein machin-
eries is therefore vital for establishing a base for launching
new therapeutics against these pathogens. Within micro-
bial proteomes, aminoacyl-tRNA synthetases have already
been exploited for drug discovery [67]. Specifically for
fungal aaRS, a novel boron-containing molecule 5-fluoro-
1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690) that
inhibits yeast cytoplasmic leucyl-tRNA synthetase by trap-
ping enzyme-bound tRNALeu in editing conformation is
now an anti-fungal agent in the market [22]. Hence,
proof-of-principle exists that can now be expanded to
BA
Figure 7 Sequence and structural analyses for tyrosyl-tRNA synthetase from C. neoformans. (A) Comparison of domain architectures for C.
neoformans TyrRS (CNBA1270) and H. sapiens cytoplasmic TyrRS based on the Pfam domain assignment. SAICAR domain at the C-terminal of
C. neoformans TyrRS is absent in the homolog from H. sapiens and these two TyrRSs are ~47% identical in the TyrRS catalytic domain region.
(B) Superimposition of modeled C. neoformans SAICAR domain in TyrRS (magenta) and crystal structure of SAICAR synthase (PDB ID 2CNQ) from
Saccharomyces cerevisiae (green) with adenosine-di-phosphate (ADP, blue). The two proteins share 51% sequence identity. Inset shows sequence and
structural conservation of ADP interacting residue in the two proteins.
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HMM-based identification and annotation confirms the
existence of all 20 aaRSs in the three studied fungal ge-
nomes. In addition, fungal DTDs, AlaXs, P43s and amido-
transferases have also been comprehensively annotated.
Putative distribution of fungal aaRSs in different sub-
cellular compartments within the fungi provides a base
for experimental validation. Our results also highlight
fungal processes that enable multiple localization of
aaRSs and/or of charged tRNAs between cytoplasmand mitochondria in these three fungi since neither their
cytoplasm nor mitochondria individually harbor a complete
set of 20 aaRSs.
Overall, the three fungal genomes harbor similar number
of aaRSs. In A. niger, C. albicans, and C. neoformans there
exist 8, 7, and 5 aaRSs that are encoded by two different
set of genes, presumably for mitochondrial localization
(Figure 1A). PheRS, GluRS, and IleRS are the three aaRSs
that are two-gene sets in all the three fungal genomes. The
distribution for aaRS associated proteins is conserved
Figure 8 Superimposition for crystal structures of human TyrRS
(white, PDBID 1N3L) and modeled structure of C. neoformans
TyrRS (light green). (A) Residues constituting ELR motif in the two
proteins are shown as spheres in red and green for human and C.
neoformans, respectively. (B) Superimposition of the ELR motifs from
the two proteins.
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neoformans Gln synthase (Gat) maybe heterodimeric
unlike its homologs in other two fungi where it is likely tobe heterotrimeric. None of the aaRS in C. neoformans were
predicted to localize within nucleus while 2 and 6 aaRSs in
A. niger and C. albicans were predicted to have nuclear
localization (Figure 1B).
The aaRSs identified in these fungal genomes share
some similarities with their human homologs (Tables 1, 2
and 3) but also many critical differences (Figures 3 and 6).
A. niger IleRS and AsxRS have unique domain fusions
which are absent in homologs from the other two fungi
and from humans (Figure 3). ValRS and TyrRS from A.
niger and C. neoformans also harbor novel functionally-
characterized domain fusions which are absent from
humans (Figures 3 and 7). Further structural and func-
tional characterization of the unique and novel fungal
aaRSs is required before they can be exploited for develop-
ment of anti-fungal compounds. In addition, experimental
analyses of fungal aaRSs that display unusual domain fu-
sions may uncover their non-canonical functions. We
found N-terminal GST_C domains in A. niger P43 which
is distinct feature for this protein in comparison to other
two fungi and humans (Figure 4). Our results also reveal
presence of novel and unique fusion proteins where do-
mains such as DUF2156 and SAICAR are appended to the
aaRS structural cores (Figures 2 and 6).
In summary, the comprehensive genomic cataloging of
aaRSs from pathogenic fungi detailed here warrants fur-
ther experimental validation and exploration. The results
presented here provide insights into protein translation
enzymes within these pathogenic fungi that can be tar-
geted for developing new drugs against these microbes.
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